Inherited mitochondrial neuropathies

Journal of the Neurological Sciences

Volumn 304, Issue 1-2, 2011, Pages 9-16

  Finsterer, Josef ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

Encephalomyopathy; Metabolic disease; Mitochondrial DNA; Multisystem disease; Nerve conduction; Neuromuscular; Neuropathy

Indexed keywords

ANTIOXIDANT; PYRUVATE DEHYDROGENASE COMPLEX; TRANSFER RNA;

ABDOMINAL PAIN; ALPERS DISEASE; ALTERNATIVE ENERGY; ASCITES; ATAXIA; ATP6 GENE; AUTOSOMAL DOMINANT OPTIC ATROPHY; BLOOD VESSEL; CACHEXIA; CARDIOMYOPATHY; CATARACT; CEREBELLAR ATAXIA; CEREBELLUM ATROPHY; CHOREA; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COGNITIVE DEFECT; CONFUSION; DEMENTIA; DEMYELINATING NEUROPATHY; DIAPHRAGM PARALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPHAGIA; DYSTONIA; EPILEPSY; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL REFLUX; GDAP1 GENE; GENE; GENE MUTATION; GENETIC DISORDER; GIANT AXONAL NEUROPATHY; GUILLAIN BARRE SYNDROME; HEARING IMPAIRMENT; HEART ARRHYTHMIA; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPOGONADISM; INFANT DISEASE; KEARNS SAYRE SYNDROME; LACTIC ACIDOSIS; LEARNING DISORDER; LEBER HEREDITARY OPTIC NEUROPATHY; LEG; LEIGH DISEASE; LIPOMATOSIS; MELAS SYNDROME; MENTAL DEFICIENCY; MERRF SYNDROME; MIGRAINE; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL ENCEPHALOMYOPATHY; MNGIE SYNDROME; MORPHOLOGY; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MYALGIA; MYELINATED NERVE; MYOCLONUS EPILEPSY; MYOPATHY; NARP SYNDROME; NAUSEA; NERVE BIOPSY; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; OPHTHALMOPLEGIA; PARESTHESIA; PARKINSONISM; POLG1 GENE; POLYNEUROPATHY; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY FAILURE; RETINOPATHY; REVIEW; SATIETY; SEIZURE; SHORT STATURE; SLEEP APNEA SYNDROME; SPASMODIC DYSPHONIA; SPASTICITY; SPINOCEREBELLAR DEGENERATION; TENDON REFLEX; TONIC CLONIC SEIZURE; TREMOR; VOMITING;

ANIMALS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MITOCHONDRIAL MYOPATHIES; MUTATION; POLYNEUROPATHIES;

EID: 79953311631     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.02.012     Document Type: Review

References (121)

1. Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009;80:1304-14.
2. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-68. (Pubitemid 36741594)
3. Corrado G, Checcarelli N, Santarone M, Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot- Marie-Tooth disease 1A. Cardiology 2006;105:142-5.
4. Chu CC, Huang CC, Fang W, Chu NS, Pang CY, Wei YH. Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 1997;37:110-5. (Pubitemid 27077812)
5. Colomer J, Iturriaga C, Bestué M, Artuch R, Briones P, Montoya J, et al. Aspects of neuropathy in mitochondrial diseases. Rev Neurol 2000;30:1117-21.
6. Finsterer J. Mitochondrial neuropathy. Clin Neurol Neurosurg 2005;107:181-6.
7. Funalot B. Peripheral neuropathies due to mitochondrial disorders. Rev Neurol (Paris) 2009;165:1118-21.
8. Chinnery PF. Mitochondrial disorders overview. [updated 2010] In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 2000. 1993-. Available from http://www.ncbi. nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mt-overview.
9. Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, et al. European Federation of Neurological Sciences. EFNS guidelines on the molecular diagnosis of mitochondrial disorders. Eur J Neurol 2009;16:1255-64.
10. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol 2010;9:829-40.
11. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
12. Santorelli FM, Tanji K, Shanske S, DiMauro S. Heterogeneous clinical presentation of the mtDNA NARP/T8993G mutation. Neurology 1997;49:270-3. (Pubitemid 27328719)
13. Thorburn DR, Rahman S. Mitochondrial DNA-associated Leigh syndrome and NARP. . [updated 2006]In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 2003. 1993-. Available fromhttp://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi? book=gene&part=narp.
14. Childs AM, Hutchin T, Pysden K, Highet L, Bamford J, Livingston J, et al. Variable phenotype including Leigh syndrome with a 9185T>C mutation in the MTATP6 gene. Neuropediatrics 2007;38:313-6. (Pubitemid 351737992)
15. Gelfand JM, Duncan JL, Racine CA, Gillum LA, Chin CT, Zhang Y, Zhang Q, Wong LJ, Roorda A, Green AJ. Heterogeneous patterns of tissue injury in NARP syndrome. J Neurol 2011;258:440-8.
16. Loiseau D, Chevrollier A, Verny C, Guillet V, Gueguen N, Pou de Crescenzo MA, et al. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease. Ann Neurol 2007;61:315-23. (Pubitemid 46676731)
17. Funalot B, Magdelaine C, Sturtz F, Ouvrier R, Vallat JM. Ultrastructural lesions of axonal mitochondria in patients with childhood-onset Charcot-Marie-Tooth disease due to MFN2 mutations. Bull Acad Natl Méd 2009;193:151-60.
18. Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 2010;30:4232-40.
19. Cassereau J, Chevrollier A, Gueguen N, Malinge MC, Letournel F, Nicolas G, et al. Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K). Neurogenetics 2009;10:145-50.
20. Cassereau J, Chevrollier A, Gueguen N, Desquiret V, Verny C, Nicolas G, Dubas F, Amati-Bonneau P, Reynier P, Bonneau D, Procaccio V. Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1mutations. Exp Neurol 2011;227:31-41.
21. Crimella C, Tonelli A, Airoldi G, Baschirotto C, D'Angelo MG, Bonato S, et al. The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2 K. J Med Genet 2010;47:712-6.
22. Niemann A, Wagner KM, Ruegg M, Suter U. GDAP1 mutations differ in their effects on mitochondrial dynamics and apoptosis depending on the mode of inheritance. Neurobiol Dis 2009;36:509-20.
23. Pedrola L, Espert A, Wu X, Claramunt R, Shy ME, Palau F. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet 2005;14:1087-94. (Pubitemid 40575884)
24. Sahin-Calapoglu N, Tan M, Soyoz M, Calapoglu M, Ozcelik N. Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation). Neuromolecular Med 2009;11:106-13.
25. Wagner KM, Rüegg M, Niemann A, Suter U. Targeting and function of the mitochondrial fission factor GDAP1 are dependent on its tail-anchor. PLoS ONE 2009;4:e5160.
26. Santoro L, Manganelli F, Lanzillo R, Tessa A, Barbieri F, Pierelli F, et al. A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy. J Neurol 2006;253:869-74. (Pubitemid 44100439)
27. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3. (Pubitemid 120015131)
28. Kärppä M, Syrjälä P, Tolonen U, Majamaa K. Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA. J Neurol 2003;250:216-21. (Pubitemid 36223098)
29. Klimek A, Suomalainen A, Bratosiewicz J, Niewinowska-Rupf K, Bogucki A, Liberski PP. A case of mitochondrial myopathy with MELAS-like features and polyneuropathy: ultrastructural and molecular studies. Pol J Pathol 1997;48:197-200.
30. Rusanen H, Majamaa K, Tolonen U, Remes AM, Myllylä R, Hassinen IE. Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology 1995;45:1188-92.
31. Mizusawa H, Ohkoshi N, Watanabe M, Kanazawa I. Peripheral neuropathy of mitochondrial myopathies. Rev Neurol (Paris) 1991;147:501-7.
32. Di Trapani G, Gregori B, Servidei S, Ricci E, Sabatelli M, Tonali P. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Clin Neuropathol 1997;16:195-200. (Pubitemid 27319989)
33. Schröder JM. Neuropathy associated with mitochondrial disorders. Brain Pathol 1993;3:177-90. (Pubitemid 23139419)
34. Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJM, editor. Handbook of Muscle Disease, vol. 1. New York: Marcel Dekker Inc; 1996. p. 479-504.
35. Naini AB, Lu J, Kaufmann P, Bernstein RA, Mancuso M, Bonilla E, et al. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol 2005;62:473-6. (Pubitemid 40349486)
36. van de Glind G, de Vries M, Rodenburg R, Hol F, Smeitink J, Morava E. Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation. Eur J Paediatr Neurol 2007;11:243-6. (Pubitemid 46832168)
37. Horvath R, Kley RA, Lochmuller H, Vorgerd M. Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys. Neurology 2007;68:56-8. (Pubitemid 46058553)
38. Peng Y, Crumley R, Ringman JM. Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA. Mov Disord 2003;18:716-8. (Pubitemid 36790293)
39. Wiedemann FR, Bartels C, Kirches E, Mawrin C, Wallesch CW. Unusual presentations of patients with the mitochondrial MERRF mutation A8344G. Clin Neurol Neurosurg 2008;110:859-63.
40. Mancuso M, Filosto M, Bellan M, Liguori R, Montagna P, Baruzzi A, et al. POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. Neurology 2004;62:316-8. (Pubitemid 38167151)
41. Nagashima T, Kato H, Maguchi S, Chuma T, Mano Y, Goto Y, et al. A mitochondrial encephalo-myo-neuropathy with a nucleotide position 3271 (T-C) point mutation in the mitochondrial DNA. Neuromuscul Disord 2001;11:470-6. (Pubitemid 32510007)
42. Schoffer K, Grant I. Multiple lipomas, alcoholism, and neuropathy: Madelung's disease or MERRF? Muscle Nerve 2006;33:142-6.
43. Erol I, Alehan F, Horvath R, Schneiderat P, Talim B. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys. Neuromuscul Disord 2009;19:275-8.
44. Naumann M, Kiefer R, Toyka KV, Sommer C, Seibel P, Reichmann H. Mitochondrial dysfunction with myoclonus epilepsy and ragged-red fibers point mutation in nerve, muscle, and adipose tissue of a patient with multiple symmetric lipomatosis. Muscle Nerve 1997;20:833-9. (Pubitemid 27250669)
45. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet 2002;39:162-9. (Pubitemid 34252551)
46. Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 1999;19:28-33. (Pubitemid 30249281)
47. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V, Lamminen T, Sonninen P, et al. Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995;59:160-4.
48. Watanabe Y, Odaka M, Hirata K. Case of Leber's hereditary optic neuropathy with mitochondrial DNA 11778 mutation exhibiting cerebellar ataxia, dilated cardiomyopathy and peripheral neuropathy. Brain Nerve 2009;61:309-12.
49. Gilhuis HJ, Schelhaas HJ, Cruysberg JR, Zwarts MJ. Demyelinating polyneuropathy in Leber hereditary optic neuropathy. Neuromuscul Disord 2006;16:394-5. (Pubitemid 43866495)
50. Zoccolella S, Torraco A, Amati A, Lamberti P, Serlenga L, Papa S, et al. Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA. Funct Neurol 2006;21:39-41. (Pubitemid 43985843)
51. Riera AR, Kaiser E, Levine P, Schapachnik E, Dubner S, Ferreira C, et al. Kearns-Sayre syndrome: electro-vectorcardiographic evolution for left septal fascicular block of the his bundle. J Electrocardiol 2008;41:675-8.
52. Hourani RG, Barada WM, Al-Kutoubi AM, Hourani MH. Atypical MRI findings in Kearns-Sayre syndrome: T2 radial stripes. Neuropediatrics 2006;37:110-3. (Pubitemid 43980093)
53. Poulton J, Macaulay V, Marchington DR. Mitochondrial genetics '98 is the bottleneck cracked? Am J Hum Genet 1998;62:752-7.
54. McDonald DG, McMenamin JB, Farrell MA, Droogan O, Green AJ. Familial childhood onset neuropathy and cirrhosis with the 4977 bp mitochondrial DNA deletion. Am J Med Genet 2002;111:191-4. (Pubitemid 34809503)
55. Consalvo D, Villegas F, Villa AM, Köhler G, Molina H, Benchuga E, et al. Severe cardiac failure in Kearns-Sayre syndrome. Medicina (B Aires) 1997;57:67-71. (Pubitemid 127511122)
56. Eymard B, Penicaud A, Leger JM, Romero N, Marsac C, Fardeau M, et al. Clinical and electrophysiologic study of the peripheral nerve in 28 cases of mitochondrial disease. Rev Neurol (Paris) 1991;147:508-12.
57. Zanssen S, Molnar M, Buse G, Schröder JM. Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy. Clin Neuropathol 1998;17:291-6. (Pubitemid 28505756)
58. Molnar M, Neudecker S, Schröder JM. Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy, Kearns-Sayre syndrome, progressive external ophthalmoplegia and MELAS. Neuropathol Appl Neurobiol 1995;21:432-9.
59. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004;364:875-82. (Pubitemid 39221065)
60. Van Goethem G, Dermaut B, Löfgren A, Martin JJ, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 2001;28:211-2. (Pubitemid 32626018)
61. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28:223-31. (Pubitemid 32626024)
62. Kaukonen J, Juselius JK, Tiranti V, Kyttala A, Zeviani M, Comi GP, et al. Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 2000;289:782-5. (Pubitemid 30650199)
63. Melberg A, Lundberg PO, Henriksson KG, Olsson Y, Stålberg E. Muscle-nerve involvement in autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle Nerve 1996;19:751-7. (Pubitemid 26134586)
64. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996;39:343-51. (Pubitemid 26100758)
65. Rossi A, Biancheri R, Bruno C, Di Rocco M, Calvi A, Pessagno A, et al. Leigh syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. Am J Neuroradiol 2003;24:1188-91. (Pubitemid 36734249)
66. Makino M, Horai S, Goto Y, Nonaka I. Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome. Neuromuscul Disord 1998;8:149-51. (Pubitemid 28246109)
67. Debray FG, Lambert M, Lortie A, Vanasse M, Mitchell GA. Long-term outcome of Leigh syndrome caused by the NARP-T8993C mtDNA mutation. Am J Med Genet A 2007;143A:2046-51.
68. Tsao CY, Mendell JR, Bartholomew D. High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes. J Child Neurol 2001;16:533-5. (Pubitemid 32725393)
69. Weraarpachai W, Antonicka H, Sasarman F, Seeger J, Schrank B, Kolesar JE, et al. Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome. Nat Genet 2009;41:833-7.
70. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, Hjerrild M, et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 2003;100:605-10. (Pubitemid 36126099)
71. Lissens W, De Meirleir L, Seneca S, Liebaers I, Brown GK, Brown RM, et al. Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency. Hum Mutat 2000;15:209-19.
72. Jacobs JM, Harding BN, Lake BD, Payan J, Wilson J. Peripheral neuropathy in Leigh's disease. Brain 1990;113:447-62. (Pubitemid 20136152)
73. Malandrini A, Palmeri S, Fabrizi GM, Villanova M, Berti G, Salvadori C, et al. Juvenile Leigh syndrome with protracted course presenting as chronic sensory motor neuropathy, ataxia, deafness and retinitis pigmentosa: a clinicopathological report. J Neurol Sci 1998;155:218-21. (Pubitemid 28139026)
74. Coker SB. Leigh disease presenting as Guillain-Barré syndrome. Pediatr Neurol 1993;9:61-3. (Pubitemid 23070100)
75. Chabrol B, Mancini J, Benelli C, Gire C, Munnich A. Leigh syndrome: pyruvate dehydrogenase defect. A case with peripheral neuropathy. J Child Neurol 1994;9:52-5. (Pubitemid 24022142)
76. Stickler DE, Carney PR, Valenstein ER. Juvenile-onset Leigh syndrome with an acute polyneuropathy at presentation. J Child Neurol 2003;18:574-6. (Pubitemid 37098636)
77. Goebel HH, Bardosi A, Friede RL, Kohlschütter A, Albani M, Siemes H. Sural nerve biopsy studies in Leigh's subacute necrotizing encephalomyelopathy. Muscle Nerve 1986;9:165-73. (Pubitemid 16068915)
78. Debouverie M, Wagner M, Ducrocq X, Grignon Y, Mousson B, Weber M. MNGIE syndrome in 2 siblings. Rev Neurol (Paris) 1997;153:547-53.
79. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-7. (Pubitemid 24130006)
80. Said G, Lacroix C, Planté-Bordeneuve V, Messing B, Slama A, Crenn P, et al. Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation. J Neurol 2005;252:655-62. (Pubitemid 40864038)
81. Bedlack RS, Vu T, Hammans S, Sparr SA, Myers B, Morgenlander J, et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2004;29:364-8. (Pubitemid 38269754)
82. Hamano H, Ohta T, Takekawa Y, Kouda K, Shinohara Y. Mitochondrial neurogastrointestinal encephalomyopathy presenting with protein-losing gastroenteropathy and serum copper deficiency: a case report. Rinsho Shinkeigaku 1997;37:917-22. (Pubitemid 28071187)
83. Gago MF, Rosas MJ, Guimarães J, Ferreira M, Vilarinho L, Castro L, et al. SANDO: two novel mutations in POLG1 gene. Neuromuscul Disord 2006;16:507-9. (Pubitemid 44332924)
84. Milone M, Brunetti-Pierri N, Tang LY, Kumar N, Mezei MM, Josephs K, et al. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 2008;18:626-32.
85. Mano A, Kikukawa H, Tsuchiya T, Tanaka K, Tanaka M. A case of mitochondrial myopathy with external ophthalmoplegia and ataxic neuropathy. Rinsho Shinkeigaku 2003;43:564-7. (Pubitemid 38036126)
86. Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006;129:1685-92. (Pubitemid 43999403)
87. Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 2008;29:E150-72.
88. Okun MS, Bhatti MT. SANDO: another presentation of mitochondrial disease. Am J Ophthalmol 2004;137:951-3. (Pubitemid 38582059)
89. Posada IJ, Gallardo ME, Domínguez C, Rivera H, Cabello A, Arenas J, et al. Mitochondrial DNA depletion and POLG mutations in a patient with sensory ataxia, dysarthria and ophthalmoplegia. Med Clin (Barc) 2010;135:452-5.
90. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, et al. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 2005;77:430-41. (Pubitemid 41192649)
91. Hakonen AH, Isohanni P, Rantamäki M, Kälviäinen R, Nordin A, Uusimaa J, et al. Mitochondrial recessive ataxia syndrome (MIRAS) and valproate toxicity. Duodecim 2010;126:1552-9.
92. Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 2008;17:3822-35.
93. Galassi G, Lamantea E, Invernizzi F, Tavani F, Pisano I, Ferrero I, et al. Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy. Neuromuscul Disord 2008;18:465-70.
94. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, et al. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 2006;59:859-62. (Pubitemid 43673164)
95. Gordon N. Alpers syndrome: progressive neuronal degeneration of children with liver disease. Dev Med Child Neurol 2006;48:1001-3. (Pubitemid 44768806)
96. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann Neurol 2005;58:491. (Pubitemid 41266643)
97. Di Fonzo A, Bordoni A, Crimi M, Sara G, Del Bo R, Bresolin N, et al. POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 2003;22:498-9.
98. Horvath R, Hudson G, Ferrari G, Fütterer N, Ahola S, Lamantea E, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Brain 2006;129:1674-84. (Pubitemid 43999402)
99. Davidzon G, Mancuso M, Ferraris S, Quinzii C, Hirano M, Peters HL, et al. POLG mutations and Alpers syndrome. Ann Neurol 2005;57:921-3. (Pubitemid 40798632)
100. Kollberg G, Moslemi AR, Darin N, Nennesmo I, Bjarnadottir I, Uvebrant P, et al. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol 2006;65:758-68. (Pubitemid 44200316)
101. Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lönnqvist T. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 2007;130:3032-40. (Pubitemid 350033977)
102. Uusimaa J, Finnilä S, Vainionpää L, Kärppä M, Herva R, Rantala H, et al. A mutation in mitochondrial DNA-encoded cytochrome c oxidase II gene in a child with Alpers-Huttenlocher-like disease. Pediatrics 2003;111:e262-8.
103. Lamperti C, Zeviani M. Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk. Acta Myol 2009;28:2-11.
104. Simonati A, Filosto M, Tomelleri G, Savio C, Tonin P, Polo A, et al. Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease. J Neurol 2003;250:702-6. (Pubitemid 36718359)
105. Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 2008;29:330-1.
106. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic communication. Biosci Rep 2007;27:39-51. (Pubitemid 46940937)
107. Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D'Adamo P, Calvo S, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006;38:570-5.
108. Johnsen SD, Johnson PC, Stein SR. Familial sensory autonomic neuropathy with arthropathy in Navajo children. Neurology 1993;43:1120-5. (Pubitemid 23177710)
109. Karadimas CL, Vu TH, Holve SA, Chronopoulou P, Quinzii C, Johnsen SD, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006;79:544-8. (Pubitemid 44384263)
110. Appenzeller O, Kornfeld M, Snyder R. Acromutilating, paralyzing neuropathy with corneal ulceration in Navajo children. Arch Neurol 1976;33:733-8.
111. Lawlor MW, Holve S, Stubbs Jr EB. Assessment of serum-mediated neurotoxicity in Navajo neuropathy. Electromyogr Clin Neurophysiol 2000;40:211-4. (Pubitemid 30426656)
112. Lönnqvist T, Paetau A, Nikali K, von Boguslawski K, Pihko H. Infantile onset spinocerebellar ataxia with sensory neuropathy (IOSCA): neuropathological features. J Neurol Sci 1998;161:57-65. (Pubitemid 28559184)
113. Nikali K, Suomalainen A, Saharinen J, Kuokkanen M, Spelbrink JN, Lönnqvist T, et al. Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky. Hum Mol Genet 2005;14:2981-90. (Pubitemid 41535463)
114. Koskinen T, Sainio K, Rapola J, Pihko H, Paetau A. Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA). Muscle Nerve 1994;17:509-15. (Pubitemid 24143330)
115. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissière A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008;131:338-51.
116. Liguori M, La Russa A, Manna I, Andreoli V, Caracciolo M, Spadafora P, et al. A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation. J Neurol 2008;255:127-9.
117. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008;131:329-37. (Pubitemid 351197604)
118. Voo I, Allf BE, Udar N, Silva-Garcia R, Vance J, Small KW. Hereditary motor and sensory neuropathy type VI with optic atrophy. Am J Ophthalmol 2003;136: 670-7. (Pubitemid 37153182)
119. Al-Dosary M, Whittaker RG, Haughton J, McFarland R, Goodship J, Turnbull DM, et al. Neuromuscular disease presentation with three genetic defects involving two genomes. Neuromuscul Disord 2009;19:841-4.
120. Spiegel R, Shaag A, Edvardson S, Mandel H, Stepensky P, Shalev SA, et al. SLC25A19 mutation as a cause of neuropathy and bilateral striatal necrosis. Ann Neurol 2009;66:419-24.
121. Gómez-Zaera M, Strom TM, Rodríguez B, Estivill X, Meitinger T, Nunes V. Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab 2001;72:72-81. (Pubitemid 34169354)